Why We Still Need the Better Risk Classification for GIST

Ann Surg Oncol. 2021 May;28(5):2425-2427. doi: 10.1245/s10434-021-09620-9. Epub 2021 Feb 24.

Author

Piotr Rutkowski¹

Affiliation

¹ Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland. piotr.rutkowski@pib-nio.pl.

PMID: 33625633
DOI: 10.1245/s10434-021-09620-9

No abstract available

Publication types

Editorial

MeSH terms

Gastrointestinal Stromal Tumors*
Humans
Prognosis